Department of Emergency Surgery, Beijing Geriatric Hospital, Beijing, China.
Department of Orthopedics, Beijing Geriatric Hospital, Beijing, China.
Medicine (Baltimore). 2024 Sep 27;103(39):e39838. doi: 10.1097/MD.0000000000039838.
Paronychia is a prevalent clinical disease profoundly affecting patients' quality of life. As ongoing evolution in modern living environments, factors contributing to paronychia are becoming increasingly diverse. Therefore, a further understanding about latest trend of paronychia is imperative and pressing.
A systematic literature search was performed based on Web of Science Core Collection and Science Citation Index Expanded. The search parameters encompassed keywords associated with paronychia from 1980 to 2023, and rigorous data cleaning procedures were executed to maintain the analysis's relevance and dependability, supplemented by a thorough examination of abstracts and titles. Visibility analysis was conducted with Citespace and VOSviewer tools to explore the publication trends, collaborative networks, and impactful studies.
A total of 595 articles were included in this study. The annual publication trends exhibited a significant increase since 1990, reached a peak of 41 articles in 2021. Collaborative relationships among countries demonstrated strong connections, with the United States leading in both publication volume, citation records and international cooperation. Keyword analysis indicated that in recent years, a substantial body of research has concentrated on paronychia issues caused by epidermal growth factor receptor inhibitors (EGFRI)-class drugs, such as Gefitinib, Erlotinib, and Afatinib, in the context of tumor treatment.
In this area, most of the recent hotspots are not focused on the basic research about paronychia due to the basic research about traditional paronychia already reached a relative mature stage. However, with the widespread clinical application of EGFRI anticancer drugs, the incidence of drug-induced paronychia is inevitably on the rise. Therefore, with the expanding diversity in the etiology of paronychia, this area deserves a multiple discipline cooperation with a much wider international communication.
甲沟炎是一种常见的临床疾病，严重影响患者的生活质量。随着现代生活环境的不断演变，导致甲沟炎的因素变得越来越多样化。因此，了解甲沟炎的最新趋势迫在眉睫。
基于 Web of Science 核心合集和科学引文索引扩展数据库进行系统文献检索。检索参数包括 1980 年至 2023 年与甲沟炎相关的关键词，并通过严格的数据清理程序来保持分析的相关性和可靠性，同时还对摘要和标题进行了全面审查。使用 Citespace 和 VOSviewer 工具进行可视化分析，以探讨发表趋势、合作网络和有影响力的研究。
本研究共纳入 595 篇文章。1990 年以来，年发表趋势呈显著上升趋势，2021 年达到 41 篇的峰值。国家间的合作关系显示出很强的联系，美国在发表数量、引用记录和国际合作方面均处于领先地位。关键词分析表明，近年来，大量研究集中在表皮生长因子受体抑制剂（EGFRIs）类药物引起的甲沟炎问题上，如 Gefitinib、Erlotinib 和 Afatinib 等，这些药物用于肿瘤治疗。
在这一领域，由于传统甲沟炎的基础研究已经相对成熟，最近的热点大多不是集中在甲沟炎的基础研究上。然而，随着 EGFRIs 抗癌药物的广泛临床应用，药物引起的甲沟炎的发生率不可避免地呈上升趋势。因此，随着甲沟炎病因的多样性不断增加，该领域需要多学科合作，并进行更广泛的国际交流。
